MARGARET KELLOGG: Open Payments
NPI 1235208935 · HONESDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 75 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $590 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $408 |
| Phathom Pharmaceuticals, Inc. | 18 | $393 |
| Madrigal Pharmaceuticals | 6 | $188 |
| Novo Nordisk Inc | 4 | $65 |
| Janssen Biotech, Inc. | 3 | $53 |
| ABBVIE INC. | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 3 | $46 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: XIFAXAN, VOQUEZNA, REZDIFFRA, Wegovy, TREMFYA, DUPIXENT, VIBERZI, ZENPEP.
Industry payments across PA — which companies pay providers there.
